All In MedTech

FDA Clearance Tracker · P990018-S005

Menicon Z Night (tisilfocon A) Contact Lenses for Overnight Wear

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 6, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 6, 2019

Approved

Time to decision

343 days

Received Nov 28, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P990018-S005
Device name
Menicon Z Night (tisilfocon A) Contact Lenses for Overnight Wear
Applicant location
Nagoya
Received
Nov 28, 2018
Decided
Nov 6, 2019
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P990018

Device type

Device class
Class III
Regulation
21 CFR 886.5916
Specialty
Ophthalmology

Every decision under product code NUU

FDA's approval statement

As written in FDA's record.

Approval for manufacture, market and distribute overnight orthokeratology contact lenses from the Menicon Z (tisilfocon A) rigid gas permeable contact lens material.

Source documents

Other decisions for Menicon Co, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.